Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIDIN-T vs ALPHAGAN-P in Glaucoma and Ocular Hypertension
NCT04647461Phase 4Unknown
- Sponsor
- CHA University
- Start
- Mar 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine in Glaucoma, ocular hypertension, sponsored by CHA University. Status: unknown.
02
Drugs
brimonidine
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT04647461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04647461.